Charles F. Bass is named as a lobbyist on federal disclosure filings for 10 clients through Greenberg Traurig, LLP and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Taxation/Internal Revenue Code, Education, Health Issues and Trade (domestic/foreign).
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| STELLAR ENERGY GLOBAL INFRASTRUCTURE (FORMERLY KNOWN AS STELLAR ENERGY) | GREENBERG TRAURIG, LLP | Q3 2026 | Taxation/Internal Revenue Code, Energy/Nuclear, Environment/Superfund |
| ONO PHARMACEUTICAL CO., LTD (FORMERLY ONO PHARMA USA) | GREENBERG TRAURIG, LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| INTERNATIONAL EDUCATION CORPORATION | GREENBERG TRAURIG, LLP | Q3 2026 | Education |
| IMPACT HEALTH SHARING | GREENBERG TRAURIG, LLP | Q3 2026 | Taxation/Internal Revenue Code, Health Issues |
| C&S WHOLESALE GROCERS INC. | GREENBERG TRAURIG, LLP | Q3 2026 | Agriculture, Defense, Food Industry (safety, labeling, etc.) |
| ATERNIUM, INC. | GREENBERG TRAURIG, LLP | Q3 2026 | Defense, Energy/Nuclear, Chemicals/Chemical Industry |
| C&S WHOLESALE GROCERS, INC. | BASSGLP LLC | Q2 2026 | Manufacturing |
| CEDIA | GREENBERG TRAURIG, LLP | Q1 2026 | Trade (domestic/foreign), Labor Issues/Antitrust/Workplace, Education |
| BORALEX US DEVELOPMENT, LLC | GREENBERG TRAURIG, LLP | Q3 2025 | Taxation/Internal Revenue Code, Energy/Nuclear, Trade (domestic/foreign) |
| INTRINSIC THERAPEUTICS, INC. | GREENBERG TRAURIG, LLP | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 8 | 2 |
| 2025 | 8 | 2 |
| Year | Items | Total |
|---|---|---|
| 2026 | 4 | $2K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Charles F. Bass. See the Capitol Clarity rankings and method.